Biomarker and Other Eligibility Criteria May Contribute to Underrepresentation in Alzheimer’s Trials
UCI MIND Director, Dr. Joshua Grill, is quoted in Neurology Today for his work with colleagues at USC, Massachusetts General Hospital, Brigham and Women’s Hospital, and Eisai on racial and ethnic disparities in eligibility for Alzheimer’s disease clinical trials.